New and Emerging Respiratory Virus Threats Advisory Group

The New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) is an advisory body that advises the United Kingdom Government's Chief Medical Advisor / Chief Medical Officer for England, who in turn advises the UK Department of Health and Social Care and relevant ministers regarding threats from viral respiratory tract infections. The body replaced the UK Scientific Pandemic Influenza Advisory Committee (SPI) as part of a move to expand the scope to cover the threat of other respiratory viruses, besides pandemic influenza. The inaugural meeting was held on 19 December 2014 where the terms of reference were agreed. The group has been advising the Department of Health for some years and minutes of meetings are now regularly published, backdated to 2014. As of 2020, the group has been advising specifically on the COVID-19 pandemic.[1][2]


On 18 December 2020, a telecon meeting took place where the SARS-Cov-2 variant, Variant of Concern 202012/01, was discussed. A summary recorded in the advisory group's minutes stated that they had "moderate confidence" that there was "a substantial increase in transmissibility" with Variant of Concern 202012/01 over other variants.[3] A summary presented to the United Kingdom Government's Scientific Advisory Group for Emergencies on 21 January 2021 recorded "a realistic possibility that infection with VOCB.1.1.7 is associated with an increased risk of death compared to infection with non-VOC viruses".[4]


As of July 2020, its members were:[1]

See alsoEdit


  1. ^ a b "New and Emerging Respiratory Virus Threats Advisory Group". GOV.UK. Retrieved 18 July 2020.{{cite web}}: CS1 maint: url-status (link)
  2. ^ Ruth Parry (6 July 2016). "The New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) - 1st Annual Report December 2014-December2015". New & Emerging Respiratory Threats Advisory Group. Retrieved 27 December 2020. NERVTAG meeting 19 December 2014: As this was the first meeting of the group the Terms of Reference were agreed...
  3. ^ "NERVTAG meetingon SARS-CoV-2 variant under investigation VUI-202012/01". New and Emerging Respiratory Virus Threats Advisory Group. 18 December 2020. Retrieved 27 December 2020.
  4. ^ Peter Horby, Catherine Huntley, Nick Davies, John Edmunds, Neil Ferguson, Graham Medley, Calum Semple (11 February 2021). "NERVTAG note on B.1.1.7 severity for SAGE 77". New and Emerging Respiratory Virus Threats Advisory Group. Retrieved 14 February 2021.{{cite web}}: CS1 maint: multiple names: authors list (link)

External linksEdit